查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1855817

無細胞DNA（cfDNA）血液採集管全球市場報告（2025年）

Cell-Free DNA (cfDNA) Blood Collection Tube Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，無細胞DNA（cfDNA）血液採集管的市場規模迅速擴張，從2024年的11.7億美元成長到2025年的13.3億美元，複合年成長率達13.8%。這一成長主要受以下因素驅動：生活方式相關疾病的日益普遍、早期基因篩檢計畫的推廣、基於血液的生物標記研究的廣泛應用、全球診斷實驗室數量的成長以及人們對母嬰健康監測意識的提高。

預計未來幾年，無細胞DNA（cfDNA）血液採集管市場將快速成長，到2029年市場規模將達到22億美元，複合年成長率（CAGR）為13.4%。預測期內的成長預計將受到以下因素的推動：患者對微創手術的偏好日益增強、cfDNA在移植監測中的廣泛應用、政府加大舉措推廣分子診斷、對高效樣本運輸和儲存的需求不斷成長，以及分子診斷檢測的保險覆蓋範圍擴大。預測期內的主要偏好包括：微流體控血液採集管技術的進步、永續和環保型血液採集管材料的創新、人工智慧在數據驅動診斷中的應用、產前和腫瘤檢測流程的改進，以及伴隨診斷在標靶治療中的應用。

無細胞DNA (cfDNA) 採集管是專門用於採集、穩定和運輸血液樣本以進行cfDNA分析的裝置。它們含有防腐劑，可保護核酸免受分解，並最大限度地減少白血球基因組DNA的釋放。這些採集管有助於在液態切片、產前檢測和癌症診斷等下游應用中獲得準確可靠的結果。

無細胞DNA（cfDNA）血液採集管市場主要由5毫升和10毫升的採集管組成。 5毫升cfDNA血液採集管是一種小容量選擇，常用於個人或常規樣本採集。樣本類型包括血漿、血清和全血。應用領域涵蓋體外診斷和科學研究。主要終端使用者包括診斷實驗室、醫院、臨床中心、基因診斷實驗室、癌症研究中心、研發機構和傳統診斷機構。

美國關稅的快速上漲以及隨之而來的2025年春季貿易摩擦，正對醫療設備產業產生重大影響，尤其是進口診斷影像設備零件、手術用不銹鋼和塑膠耗材。醫院和診所都在抵制價格上漲，這擠壓了製造商的淨利率。監管障礙加劇了這個問題，因為與關稅相關的供應商變更通常需要重新認證設備，從而延緩產品上市時間。企業正透過關鍵零件的雙重採購、擴大國內同質化產品的生產以及加速研發經濟高效材料來降低風險。

本研究報告是商業研究公司（The Business Research Company）最新系列報告的一部分，提供無細胞DNA（cfDNA）採血管市場統計數據，包括全球市場規模、區域佔有率、競爭對手及其市場佔有率、詳細的市場細分、市場趨勢和機遇，以及您在無細胞DNA（cfDNA）採血管行業取得成功所需的數據。本無細胞DNA（cfDNA）採血管市場研究報告對產業現狀和未來發展趨勢進行了詳細分析，為您提供所需的一切資訊。

預計未來幾年，呼吸系統疾病的日益普遍將推動無細胞DNA（cfDNA）採集管市場的成長。呼吸系統疾病是指影響肺部及呼吸系統其他部位的疾病，這些疾病會導致呼吸困難，影響血液供氧和二氧化碳排出。呼吸系統疾病盛行率的上升主要是由於空氣污染，空氣污染會刺激呼吸道，降低肺功能，並增加氣喘、支氣管炎、慢性阻塞性肺病（COPD）和其他疾病的風險。無細胞DNA（cfDNA）採集管在呼吸系統疾病管理中發揮關鍵作用，它可以透過簡單的血液檢測來檢測基因突變、追蹤疾病進展並評估治療效果，從而減少侵入性肺部切片檢查的需求。例如，2024 年 12 月，美國政府機構疾病管制與預防中心 (CDC) 報告稱，據估計，2024 年 10 月 1 日至 11 月 30 日期間，呼吸道融合細胞病毒(RSV) 導致 17,000 至 34,000 人住院。呼吸道疾病發生率的上升正在推動 cfDNA 採集管的需求。

癌症發生率的上升預計將推動無細胞DNA（cfDNA）採集管市場的未來成長。 cfDNA採集管擴大用於癌症治療中的液態生物檢體液態切片，透過簡單的血液檢測即可檢測腫瘤特異性基因突變、監測疾病進展、評估治療反應並識別抗藥性突變。這種方法減少了侵入性組織切片檢查的需求。例如，美國國家癌症研究所（美國政府機構）在2024年5月預測，美國癌症倖存者人數將從2022年的1810萬人增加到2040年的26​​00萬人。因此，癌症發生率的上升正在推動cfDNA採集管的需求。

在cfDNA血液採集管市場運作的主要企業正致力於實現cfDNA提取的自動化，以提高工作流程效率。 cfDNA提取自動化是指利用先進的機器人系統和標準化流程，以最少的人工干預從血液樣本中分離遊離DNA，從而提高效率、準確性和一致性，同時縮短週轉時間並減少人為錯誤。例如，英國分子診斷公司Yourgene Health plc於2023年9月推出了MagBench自動化DNA萃取儀和試劑盒。該解決方案提供了一種快速、便捷且經濟高效的桌上型機器人方案，專為非侵入性產前檢測（NIPT）工作流程中的cfDNA提取而最佳化。此次發布旨在增強NIPT工作流程的自動化程度，提高cfDNA提取的通量、可重複性和可靠性，同時減少人工時間和營運成本。

無細胞DNA（cfDNA）血液採集管市場包括血漿分離管、低溫儲存系統和血漿預處理離心系統的銷售。該市場的價值為“出廠價”，即製造商或生產商向其他營業單位（包括下游製造商、經銷商、分銷商和零售商）或直接向最終客戶銷售的商品價值。該市場商品價值還包括製造商提供的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅，以及新冠疫情及其復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球無細胞DNA（cfDNA）血液採集管：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 終端用戶產業分析
  • 全球無細胞DNA（cfDNA）採血管市場：成長率分析
  • 全球無細胞DNA（cfDNA）血液採集管市場表現：規模和成長，2019-2024年
  • 全球無細胞DNA（cfDNA）血液採集管市場預測：規模和成長，2024-2029年，2034年預測
  • 全球無細胞DNA（cfDNA）血液採集管：潛在市場規模（TAM）

第6章 市場細分

  • 全球無細胞DNA（cfDNA）採血管市場：按類型、性能和預測分類，2019-2024年、2024-2029年預測、2034年預測
  • 5ml
  • 10ml
  • 全球無細胞DNA（cfDNA）血液採集管市場依樣本類型、效能及預測分類，2019-2024年、2024-2029年預測、2034年預測
  • 電漿
  • 血清
  • 全血
  • 全球無細胞DNA（cfDNA）採血管市場：依應用、效能及預測分類，2019-2024年、2024-2029年預測、2034年預測
  • 體外診斷
  • 科學研究
  • 全球無細胞DNA（cfDNA）血液採集管市場：依最終用戶、性能和預測分類，2019-2024年、2024-2029年預測、2034年預測
  • 診斷實驗室
  • 醫院或臨床中心
  • 基因診斷實驗室
  • 癌症研究中心
  • 研究與發展研究所
  • 傳統診斷中心
  • 全球無細胞DNA（cfDNA）採血管市場：依5毫升、類型、表現細分及預測（2019-2024年、2024-2029年預測、2034年預測）。
  • 免洗管
  • 真空採血管
  • 凝膠分離管
  • 全球無細胞DNA（cfDNA）採血管市場：10毫升細分市場：按類型分類，實際結果和預測，2019-2024年、2024-2029年預測、2034年預測
  • 雙抽管
  • 大容量採血管
  • 抗凝血劑處理過的試管

第7章 區域和國家分析

  • 全球無細胞DNA（cfDNA）血液採集管市場：按地區、績效和預測分類，2019-2024年、2024-2029年預測、2034年預測
  • 全球無細胞DNA（cfDNA）血液採集管市場：按國家/地區、性能和預測分類，2019-2024年、2024-2029年預測、2034年預測

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 無細胞DNA（cfDNA）血液採集管市場：競爭格局
  • 無細胞DNA（cfDNA）血液採集管市場：公司概況
    • Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Becton Dickinson（BD）Overview, Products and Services, Strategy and Financial Analysis
    • Qiagen NV Overview, Products and Services, Strategy and Financial Analysis
    • SARSTEDT AG & Co. KG Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Guangzhou Improve Medical Technology
  • Streck Inc.
  • DiaCarta Inc.
  • Zymo Research Corporation
  • Biomatrica Inc.
  • PreAnalytiX GmbH
  • Beijing Cowin Bioscience Co.Ltd.
  • Norgen Biotek Corporation
  • Nonacus Limited
  • Guangdong Ardent Biomed Co. Ltd
  • MagBio Genomics Inc.
  • VanGenes
  • BEAVER
  • Hebei Xinle Science & Technology Co. Ltd.
  • Nasmed Diagnostics Pvt. Ltd.

第32章 全球市場競爭基準化分析與儀錶板

第33章 重大併購

第34章 近期市場趨勢

第35章：高潛力市場國家、細分市場與策略

  • 無細胞DNA（cfDNA）血液採集管市場展望（2029）：提供新機會的國家
  • 無細胞DNA（cfDNA）血液採集管市場2029：新興細分市場機會
  • 無細胞DNA（cfDNA）血液採集管市場2029年：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章附錄

簡介目錄
Product Code: r38466

A cell-free DNA (cfDNA) blood collection tube is a specialized device designed to collect, stabilize, and transport blood samples for cfDNA analysis. It contains preservatives that protect nucleic acids from degradation and minimize the release of genomic DNA from white blood cells. These tubes support accurate and reliable results in downstream applications such as liquid biopsy, prenatal testing, and cancer diagnostics.

The primary types in the cell-free DNA (cfDNA) blood collection tube market are 5 mL and 10 mL. The 5 mL cfDNA blood collection tube is a smaller-volume option commonly used for individual or routine sample collection. Sample types include plasma, serum, and whole blood. Applications cover in vitro diagnostics and scientific research. Key end-users include diagnostic laboratories, hospitals and clinical centers, genetic diagnostic labs, cancer research centers, research and development institutions, and conventional diagnostic facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The cell-free DNA (cfDNA) blood collection tube market research report is one of a series of new reports from The Business Research Company that provides cell-free DNA (cfDNA) blood collection tube market statistics, including cell-free DNA (cfDNA) blood collection tube industry global market size, regional shares, competitors with a cell-free DNA (cfDNA) blood collection tube market share, detailed cell-free DNA (cfDNA) blood collection tube market segments, market trends and opportunities, and any further data you may need to thrive in the cell-free DNA (cfDNA) blood collection tube industry. The cell-free DNA (cfDNA) blood collection tube market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cell-free DNA (cfDNA) blood collection tube market size has grown rapidly in recent years. It will grow from $1.17 billion in 2024 to $1.33 billion in 2025 at a compound annual growth rate (CAGR) of 13.8%. Growth in the historic period was driven by the increasing prevalence of lifestyle-related disorders, greater emphasis on early genetic screening programs, wider acceptance of blood-based biomarker research, growth in the number of diagnostic laboratories worldwide, and rising awareness of maternal and fetal health monitoring.

The cell-free DNA (cfDNA) blood collection tube market size is expected to see rapid growth in the next few years. It will grow to $2.20 billion in 2029 at a compound annual growth rate (CAGR) of 13.4%. Growth in the forecast period is expected to be supported by increasing patient preference for minimally invasive procedures, wider use of cfDNA in transplant monitoring, stronger government initiatives promoting molecular diagnostics, greater demand for efficient sample transport and storage, and expanded insurance coverage for molecular diagnostic tests. Key trends anticipated for the forecast period include advancements in microfluidics-enabled blood collection tubes, innovation in sustainable and eco-friendly tube materials, integration of artificial intelligence for data-driven diagnostics, improvements in prenatal and oncology testing workflows, and the use of companion diagnostics to support targeted therapies.

The rising prevalence of respiratory disorders is expected to drive the growth of the cell-free DNA (cfDNA) blood collection tube market in the coming years. Respiratory disorders are conditions that impact the lungs and other parts of the respiratory system, making it difficult to breathe properly and affecting the delivery of oxygen to the blood or removal of carbon dioxide from the body. The growing prevalence of respiratory disorders is largely attributed to air pollution, which irritates the airways, decreases lung function, and heightens the risk of conditions such as asthma, bronchitis, and chronic obstructive pulmonary disease (COPD). Cell-free DNA (cfDNA) blood collection tubes play a crucial role in managing respiratory disorders by detecting genetic mutations, tracking disease progression, and assessing treatment effectiveness with a simple blood test, reducing the need for invasive lung biopsies. For instance, in December 2024, the Centers for Disease Control and Prevention (CDC), a U.S.-based government agency, reported that between October 1 and November 30, 2024, respiratory syncytial virus (RSV) led to an estimated 17,000 to 34,000 hospitalizations. Thus, the increasing occurrence of respiratory disorders is fueling the demand for cfDNA blood collection tubes.

The rising incidence of cancer is expected to drive growth in the cell-free DNA (cfDNA) blood collection tube market in the future. The growing number of cancer cases is linked to lifestyle factors such as poor diet, smoking, and lack of physical activity. cfDNA blood collection tubes are increasingly used in cancer care for liquid biopsies, which allow for the detection of tumor-specific genetic mutations, monitoring of disease progression, evaluation of treatment responses, and identification of resistance mutations through a simple blood test. This method reduces the need for invasive tissue biopsies. For example, in May 2024, the National Cancer Institute, a U.S.-based government agency, projected that the number of cancer survivors in the U.S. would rise to 26 million by 2040, up from 18.1 million in 2022. Therefore, the growing incidence of cancer is driving the demand for cfDNA blood collection tubes.

Key companies operating in the cfDNA blood collection tube market are focusing on automating cfDNA extraction to improve workflow efficiency. Automation of cfDNA extraction involves the use of advanced robotic systems and standardized procedures to isolate cell-free DNA from blood samples with minimal manual intervention, enhancing efficiency, accuracy, and consistency while reducing turnaround times and human error. For example, in September 2023, Yourgene Health plc, a molecular diagnostics company based in the UK, introduced the MagBench Automated DNA Extraction Instrument and Kit. This solution provides a fast, simple, and cost-effective bench-top robotic option optimized for cfDNA extraction in non-invasive prenatal testing (NIPT) workflows. The launch aims to enhance automation in NIPT workflows, delivering higher throughput, reproducibility, and reliability in cfDNA extraction while reducing hands-on time and operational expenses.

Major players in the cell-free DNA (cfDNA) blood collection tube market are Roche Holding AG, Thermo Fisher Scientific Inc., Becton Dickinson (BD), Qiagen N.V., SARSTEDT AG & Co. KG, Guangzhou Improve Medical Technology, Streck Inc., DiaCarta Inc., Zymo Research Corporation, Biomatrica Inc., PreAnalytiX GmbH, Beijing Cowin Bioscience Co.Ltd., Norgen Biotek Corporation, Nonacus Limited, Guangdong Ardent Biomed Co. Ltd, MagBio Genomics Inc., VanGenes, BEAVER, Hebei Xinle Science & Technology Co. Ltd., Nasmed Diagnostics Pvt. Ltd.

North America was the largest region in the cell-free DNA (cfDNA) blood collection tube market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cell-free DNA (cfDNA) blood collection tube report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cell-free DNA (cfDNA) blood collection tube market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cell-free DNA (cfDNA) blood collection tube market consists of sales of plasma separation tubes, cryogenic storage systems, and plasma prep centrifugation systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell-Free DNA (cfDNA) Blood Collection Tube Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cell-free dna (cfdna) blood collection tube market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell-free dna (cfdna) blood collection tube ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cell-free dna (cfdna) blood collection tube market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: 5ml; 10ml
  • 2) By Sample Type: Plasma; Serum; Whole Blood
  • 3) By Application: In Vitro Diagnostics; Scientific Research
  • 4) By End-User: Diagnostic Laboratories; Hospitals Or Clinical Centers; Genetic Diagnostic Labs; Cancer Research Centers; Research And Development Institutions; Conventional Diagnostic Centers
  • Subsegments:
  • 1) By 5 mL: Single Use Tube; Vacuum Blood Collection Tube; Gel Separator Tube
  • 2) By 10 mL: Double Draw Tube; High Volume Collection Tube; Anticoagulant Treated Tube
  • Companies Mentioned: Roche Holding AG; Thermo Fisher Scientific Inc.; Becton Dickinson (BD); Qiagen N.V.; SARSTEDT AG & Co. KG; Guangzhou Improve Medical Technology; Streck Inc.; DiaCarta Inc.; Zymo Research Corporation; Biomatrica Inc.; PreAnalytiX GmbH; Beijing Cowin Bioscience Co.Ltd.; Norgen Biotek Corporation; Nonacus Limited; Guangdong Ardent Biomed Co. Ltd; MagBio Genomics Inc.; VanGenes; BEAVER; Hebei Xinle Science & Technology Co. Ltd.; Nasmed Diagnostics Pvt. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cell-Free DNA (cfDNA) Blood Collection Tube Market Characteristics

3. Cell-Free DNA (cfDNA) Blood Collection Tube Market Trends And Strategies

4. Cell-Free DNA (cfDNA) Blood Collection Tube Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cell-Free DNA (cfDNA) Blood Collection Tube Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Cell-Free DNA (cfDNA) Blood Collection Tube PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Cell-Free DNA (cfDNA) Blood Collection Tube Market Growth Rate Analysis
  • 5.4. Global Cell-Free DNA (cfDNA) Blood Collection Tube Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Cell-Free DNA (cfDNA) Blood Collection Tube Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Cell-Free DNA (cfDNA) Blood Collection Tube Total Addressable Market (TAM)

6. Cell-Free DNA (cfDNA) Blood Collection Tube Market Segmentation

  • 6.1. Global Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 5ml
  • 10ml
  • 6.2. Global Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Plasma
  • Serum
  • Whole Blood
  • 6.3. Global Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • In Vitro Diagnostics
  • Scientific Research
  • 6.4. Global Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostic Laboratories
  • Hospitals Or Clinical Centers
  • Genetic Diagnostic Labs
  • Cancer Research Centers
  • Research And Development Institutions
  • Conventional Diagnostic Centers
  • 6.5. Global Cell-Free DNA (cfDNA) Blood Collection Tube Market, Sub-Segmentation Of 5Ml, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single Use Tube
  • Vacuum Blood Collection Tube
  • Gel Separator Tube
  • 6.6. Global Cell-Free DNA (cfDNA) Blood Collection Tube Market, Sub-Segmentation Of 10Ml, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Double Draw Tube
  • High Volume Collection Tube
  • Anticoagulant Treated Tube

7. Cell-Free DNA (cfDNA) Blood Collection Tube Market Regional And Country Analysis

  • 7.1. Global Cell-Free DNA (cfDNA) Blood Collection Tube Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Cell-Free DNA (cfDNA) Blood Collection Tube Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 8.1. Asia-Pacific Cell-Free DNA (cfDNA) Blood Collection Tube Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 9.1. China Cell-Free DNA (cfDNA) Blood Collection Tube Market Overview
  • 9.2. China Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 10.1. India Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 11.1. Japan Cell-Free DNA (cfDNA) Blood Collection Tube Market Overview
  • 11.2. Japan Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 12.1. Australia Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 13.1. Indonesia Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 14.1. South Korea Cell-Free DNA (cfDNA) Blood Collection Tube Market Overview
  • 14.2. South Korea Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 15.1. Western Europe Cell-Free DNA (cfDNA) Blood Collection Tube Market Overview
  • 15.2. Western Europe Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 16.1. UK Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 17.1. Germany Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 18.1. France Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 19.1. Italy Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 20.1. Spain Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 21.1. Eastern Europe Cell-Free DNA (cfDNA) Blood Collection Tube Market Overview
  • 21.2. Eastern Europe Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 22.1. Russia Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 23.1. North America Cell-Free DNA (cfDNA) Blood Collection Tube Market Overview
  • 23.2. North America Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 24.1. USA Cell-Free DNA (cfDNA) Blood Collection Tube Market Overview
  • 24.2. USA Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 25.1. Canada Cell-Free DNA (cfDNA) Blood Collection Tube Market Overview
  • 25.2. Canada Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 26.1. South America Cell-Free DNA (cfDNA) Blood Collection Tube Market Overview
  • 26.2. South America Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 27.1. Brazil Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 28.1. Middle East Cell-Free DNA (cfDNA) Blood Collection Tube Market Overview
  • 28.2. Middle East Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 29.1. Africa Cell-Free DNA (cfDNA) Blood Collection Tube Market Overview
  • 29.2. Africa Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cell-Free DNA (cfDNA) Blood Collection Tube Market Competitive Landscape And Company Profiles

  • 30.1. Cell-Free DNA (cfDNA) Blood Collection Tube Market Competitive Landscape
  • 30.2. Cell-Free DNA (cfDNA) Blood Collection Tube Market Company Profiles
    • 30.2.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Becton Dickinson (BD) Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Qiagen N.V. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. SARSTEDT AG & Co. KG Overview, Products and Services, Strategy and Financial Analysis

31. Cell-Free DNA (cfDNA) Blood Collection Tube Market Other Major And Innovative Companies

  • 31.1. Guangzhou Improve Medical Technology
  • 31.2. Streck Inc.
  • 31.3. DiaCarta Inc.
  • 31.4. Zymo Research Corporation
  • 31.5. Biomatrica Inc.
  • 31.6. PreAnalytiX GmbH
  • 31.7. Beijing Cowin Bioscience Co.Ltd.
  • 31.8. Norgen Biotek Corporation
  • 31.9. Nonacus Limited
  • 31.10. Guangdong Ardent Biomed Co. Ltd
  • 31.11. MagBio Genomics Inc.
  • 31.12. VanGenes
  • 31.13. BEAVER
  • 31.14. Hebei Xinle Science & Technology Co. Ltd.
  • 31.15. Nasmed Diagnostics Pvt. Ltd.

32. Global Cell-Free DNA (cfDNA) Blood Collection Tube Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cell-Free DNA (cfDNA) Blood Collection Tube Market

34. Recent Developments In The Cell-Free DNA (cfDNA) Blood Collection Tube Market

35. Cell-Free DNA (cfDNA) Blood Collection Tube Market High Potential Countries, Segments and Strategies

  • 35.1 Cell-Free DNA (cfDNA) Blood Collection Tube Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Cell-Free DNA (cfDNA) Blood Collection Tube Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Cell-Free DNA (cfDNA) Blood Collection Tube Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer